文献速递头颈部肿瘤放疗胸部肿瘤放疗泌尿生殖与妇科肿瘤放疗

基于每日离线计划评估的自适应放疗剂量与解剖变异行动水平:初步结果

Action Levels on Dose and Anatomic Variation for Adaptive Radiation Therapy Using Daily Offline Plan Evaluation: Preliminary Results.
PubMed 文献 · Pract Radiat Oncol · 2018-08-22

本研究利用20例患者(10例头颈、5例肺、5例前列腺癌)的每日或每周CBCT图像,开发用于重新计划的剂量和解剖变异行动水平。结果显示,计划靶区剂量差异>5%或CTV图像相关系数<0.75可作为重新计划的指标,7例未重新计划者的剂量差异<5%且CTV Pearson相关系数>75%。作者认为5%剂量差异和/或0.75 Pearson相关系数是实用的行动水平。

要点

  • 计划靶区剂量差异>5%或CTV图像相关系数<0.75可作为重新计划的指标。
  • 未重新计划的7例患者所有分次剂量差异<5%且CTV Pearson相关系数>75%。
  • 软件工具可在CBCT计划满足重新计划标准时自动通过邮件和寻呼机提醒主治医师和物理师。

核心结论

  • 作者认为,对于给定数据集,5%的剂量差异和/或0.75 Pearson相关系数的解剖变异是重新计划的实用行动水平。

研究设计与样本

  • 使用20例患者(10例头颈癌、5例肺癌、5例前列腺癌)的每日或每周CBCT图像确定行动水平,这些患者根据医师临床决策(主要基于CBCT扫描比较)接受了重新模拟定位。
  • 以首次治疗前采集的第一幅CBCT图像作为参考图像,以排除CBCT剂量不准确的影响。
  • 临床靶区(CTV)的Pearson相关系数被用作解剖变异的参数。
  • 通过比较参数与重新计划的临床决策,推导剂量和解剖变异的行动水平参数。
  • 开发了一个软件工具,利用CBCT自动执行所有流程,包括剂量计算和计划评估。

主要发现

  • 13例根据显著剂量或解剖变化临床决定重新计划。
  • 7例不需要重新计划的病例显示剂量差异<5%,且所有分次的CTV Pearson相关系数>75%。
  • 计划靶区剂量差异>5%或CTV图像相关系数<0.75被证明是重新计划的指标。
  • 一旦CBCT计划结果满足重新计划标准,软件工具自动通过电子邮件和寻呼机提醒主治医师和物理师,以便密切检查该病例。

关键数值与推荐

  • 计划靶区剂量差异>5%或CTV图像相关系数<0.75被证明是重新计划的指标。
  • 不需要重新计划的7例病例剂量差异<5%,且所有分次CTV Pearson相关系数>75%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to develop action levels for replanning to accommodate dosimetric variations resulting from anatomic changes during the course of treatments, using daily cone beam computed tomography (CBCT). METHODS AND MATERIALS: Daily or weekly CBCT images of 20 patients (10 head and neck, 5 lung, and 5 prostate cancers) who underwent resimulation per physicians' clinical decisions, mainly from the comparison of CBCT scans, were used to determine action levels. The first CBCT image acquired before the first treatment was used as the reference image to rule out effects of dose inaccuracy from the CBCT. The Pearson correlation of clinical target volume (CTV) was used as a parameter of anatomic variation. Parameters for action levels on dose and anatomic variation were deduced by comparing the parameters and clinical decisions made for replanning. A software tool was developed to automatically perform all procedures, including dose calculations, using the CBCT and plan evaluations. RESULTS: Replans were clinically decided based on either significant dose or anatomic changes in 13 cases. The 7 cases that did not require replanning showed dose differences <5%, and the Pearson correlation of the CTV was >75% for all fractions. A difference in planning target volume dose >5% or a difference in the image correlation coefficient of the CTV <0.75 proved to be indicators for replanning. Once the results of the CBCT plan met the replanning criteria, the software tool automatically alerted the attending physician and physicist by both e-mail and pager so that the case could be examined closely. CONCLUSIONS: Our study shows that a dose difference of 5% and/or anatomy variation at 0.75 Pearson correlations are practical action levels on dose and anatomic variation for replanning for the given data sets.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Zhang B, Lee SW, Chen S, et al. Action Levels on Dose and Anatomic Variation for Adaptive Radiation Therapy Using Daily Offline Plan Evaluation: Preliminary Results. Pract Radiat Oncol. 2018. PMID: 30142442. doi:10.1016/j.prro.2018.08.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。